ATYPICAL HEMOLYTIC UREMIC SYNDROME
Clinical trials for ATYPICAL HEMOLYTIC UREMIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL HEMOLYTIC UREMIC SYNDROME trials appear
Sign up with your email to follow new studies for ATYPICAL HEMOLYTIC UREMIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare blood disorder: crovalimab trial targets aHUS
Disease control OngoingThis study tests a new medicine, crovalimab, in adults and teenagers with a rare blood disease called atypical hemolytic uremic syndrome (aHUS). The goal is to see if the drug can control the disease by stopping damage to small blood vessels and improving kidney function. Partici…
Matched conditions: ATYPICAL HEMOLYTIC UREMIC SYNDROME
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 03:06 UTC
-
New hope for kids with rare kidney disease: crovalimab trial underway
Disease control OngoingThis study tests a drug called crovalimab in 41 children with atypical hemolytic uremic syndrome (aHUS), a rare condition that causes blood clots and kidney damage. The goal is to see if the drug can control the disease and improve kidney function. Participants receive crovalimab…
Matched conditions: ATYPICAL HEMOLYTIC UREMIC SYNDROME
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 15, 2026 11:57 UTC